Cephalosporin API Market Size is valued at USD 1.70 billion in 2023 and is predicted to reach USD 2.62 billion by the year 2031 at a 5.7% CAGR during the forecast period for 2024-2031.
Cephalosporin APIs are the active pharmaceutical ingredients derived from fungi, specifically Acremonium, and they form the basis of cephalosporin antibiotics like cephalexin and ceftriaxone. These APIs are crucial for treating bacterial infections and undergo rigorous production standards to ensure safety and efficacy in medications.
The global cephalosporin API market is being driven by several factors, including a surge in illnesses, an escalating demand for cephalosporin antibiotics, an upsurge in public health spending, and a growing number of biologics and biosimilars. The increasing global demand for cephalosporin active pharmaceutical ingredients (API) in pharmaceutical and laboratory settings is fueling the growth of the market. Regulatory support and government funding for antibiotic research significantly impact the growth of the market. The demand for cephalosporin active pharmaceutical components is increasing due to various factors, such as the growing number of elderly people who are more susceptible to infections and the higher healthcare expenditures by both individuals and governments.
Nevertheless, the expansion of the market requires enhancements in response to a multifaceted regulatory framework that covers the production of pharmaceuticals. This entails conducting thorough testing, exploring new alternatives to conventional medicine, addressing the escalating issue of antibiotic resistance, and mitigating the adverse effects of cephalosporin API drugs, all of which contribute to the deceleration of the cephalosporin API market growth. Furthermore, the cephalosporin Active Pharmaceutical Ingredient (API) market is seeing substantial impact from advancements in pharmaceutical manufacturing and technical enhancements. The business is projected to undergo expansion as a result of the rising prevalence of respiratory tract diseases globally, which will create prospects for market growth in the foreseeable future.
The cephalosporin API market is segmented based on product type, formulation, and consumer type. As per the product type, the market is segmented into first-generation, second-generation, third-generation, and fourth-generation. As per the formulation, the market is segmented into oral and injection. By consumer type, the market is segmented into hospital use, clinic use, and recovery centre.
The first generation of cephalosporin APIs is expected to hold a large global market share in 2023 because it is both inexpensive and efficient against a wide variety of germs. The enormous demand for first-generation antibiotics is fueled by their widespread usage in treating common bacterial illnesses. Their well-documented safety profile and proven effectiveness also make them a popular option in many medical facilities, fueling the expansion of the market.
The oral industry is growing because oral cephalosporins are useful against many types of bacterial infections, easy for patients to take, and have a high rate of patient compliance. Due to their broad acceptance in outpatient settings and the convenience of administration, oral cephalosporins are becoming an important segment of the market.
The Asia Pacific Cephalosporin API market is estimated to report the maximum market revenue share in the near future. This is because there is a lot of money invested in R&D, there is a significant prevalence of bacterial diseases, and healthcare infrastructure is quite advanced. Furthermore, the market is being backed by the presence of big pharmaceutical businesses and by regulatory regulations that are beneficial to growth in this region. In addition, Europe is expected to grow quickly in the world cephalosporin API market because of a highly developed healthcare system, substantial healthcare spending, favourable government regulations, an increasing public consciousness regarding antibiotic treatments, and a sizable patient population.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 1.70 Bn |
|
Revenue Forecast In 2031 |
USD 2.62 Bn |
|
Growth Rate CAGR |
CAGR of 5.7% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, Formulation, And Consumer Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
NCPC, Qilu Antibiotics, Dongying Pharmaceutical, SALUBRIS, LIVZON, CSPC, United Laboratories, LKPC, HPGC, Ruiying, Meiya, Kelun, Dongrui, Liguo Pharma, Fuan Pharma, Orchid Pharma, Aurobindo, Nectar Lifesciences, ACS Dobfar, Novartis and Other Market Players |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cephalosporin API Market Snapshot
Chapter 4. Global Cephalosporin API Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. First Generation
5.2.2. Second Generation
5.2.3. Third Generation
5.2.4. Fourth Generation
Chapter 6. Market Segmentation 2: by Formulation Estimates & Trend Analysis
6.1. by Formulation & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Formulation:
6.2.1. Oral
6.2.2. Injection
Chapter 7. Market Segmentation 3: By Consumer Type Estimates & Trend Analysis
7.1. By Consumer Type & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Consumer Type:
7.2.1. Hospital Use
7.2.2. Clinic Use
7.2.3. Recovery Center
Chapter 8. Cephalosporin API Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.1.2. North America Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
8.1.3. North America Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by Consumer Type, 2024-2031
8.1.4. North America Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.2.2. Europe Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
8.2.3. Europe Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts By Consumer Type, 2024-2031
8.2.4. Europe Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.3.2. Asia Pacific Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
8.3.3. Asia-Pacific Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts By Consumer Type, 2024-2031
8.3.4. Asia Pacific Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.4.2. Latin America Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
8.4.3. Latin America Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts By Consumer Type, 2024-2031
8.4.4. Latin America Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.5.2. Middle East & Africa Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2024-2031
8.5.3. Middle East & Africa Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts By Consumer Type, 2024-2031
8.5.4. Middle East & Africa Cephalosporin API Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. NCPC (North China Pharmaceutical Corporation)
9.2.2. Qilu Antibiotics
9.2.3. Dongying Pharmaceutical
9.2.4. Lupin Pharmaceuticals
9.2.5. SALUBRIS
9.2.6. LIVZON
9.2.7. CSPC (China Pharmaceutical Group)
9.2.8. United Laboratories
9.2.9. LKPC (Lupin Kanto Chemical)
9.2.10. HPGC (Hainan Pharmaceutical Group)
9.2.11. Shandong RuiyingEndospan
Cephalosporin API Market By Product Type-
Cephalosporin API Market By Formulation-
Cephalosporin API Market By Consumer Type-
Cephalosporin API Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
